HI,欢迎来到学术之家,发表咨询:400-888-7501  订阅咨询:400-888-7502  股权代码  102064
0

Cell Mechanics Regulates Cellular Uptake of Graphene Quantum Dot for Specifically Targeting Cancer Stem Cells

作者:Xi; Chen; Kai; Tang; Jinghua; Sun; Yad...cellmechanicscancerstemcellsnanoparticleendocytosis

摘要:Cancer stem cells(CSCs)are the driving force for sustainable tumor growth and metastasis and responsible for drug resistance and cancer relapse.Nanoparticle-based drug delivery has been demonstrated to be effective in combating tumor growth.However,it has been challenging to selectively eliminate CSCs due to the lack of a general signature for a spectrum of cancers.It is known that CSCs from various types of cancer show lower stiffness compared to non-CSCs.It remains unclear whether low stiffness in CSCs influences cellular uptake in nanoparticle-based drug delivery and thus the chemotherapy efficacy.Graphene quantum dot(GQD)is emerging as a promising carrier material in delivering anti-cancer drugs.We found that breast CSCs were softer than conventional cancer cells,which were further softer compared to healthy breast tissue cells.Importantly,soft CSCs uptook more GQD than conventional cancer cells,while stiff breast cancer cells with relatively low stiffness uptook more GQD than healthy breast cells.Softening cells by pharmacologically inhibiting actomyosin activity using either siRNA or actomyosin inhibitors significantly enhanced the cellular uptake of GQD in breast cancer cells but not CSCs,while stiffening cells by activating actomyosin using CA-MLCK/ROCK or actomyosin activators considerably suppressed the nanoparticle uptake in both cancer cells and CSCs.GQD could specifically target CSC because of low cell stiffness of CSC in breast cancer cell line MCF-7 and MDA-MB-231.Further regulating cell stiffness reflected that decreasing breast cancer cell stiffness by inhibiting actomyosin activity using blebbistatin could promote GQD uptake.Vice versa,stiffening cancer cell by activating actomyosin decreased GQD uptake.The attachment of anti-cancer drug doxorubicin did not alter the trend of GQD uptake in neither soften nor stiffen cancer cells.Actomyosin activity regulates cellular uptake ofGQD might through clathrin and caveolin-mediated endocytosis.Cancer cells are softer than normal cells from the same orga

注:因版权方要求,不能公开全文,如需全文,请咨询杂志社

医用生物力学

《医用生物力学》(CN:31-1624/R)是一本有较高学术价值的大型双月刊,自创刊以来,选题新奇而不失报道广度,服务大众而不失理论高度。颇受业界和广大读者的关注和好评。 《医用生物力学》主要刊登交流我国学者在生物力学研究中取得的成果和部分国外专家的论文。着重刊登对科研与临床实践有指导意义的论著,同时还开辟综述、讲座、经验交流、研究简报、专题讨论等专栏。内容充实,反映了中国生物力学的研究动向和成果。

杂志详情